Clinical trials
Endometriosis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 6 |
| Enrolling by invitation | 4 |
| Terminated | 4 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BC Women's Hospital & Health Centre | 6 |
| Bayer | 3 |
| AbbVie | 2 |
| Kissei Pharmaceutical Co., Ltd. | 2 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 2 |
| McMaster University | 2 |
| Myovant Sciences GmbH | 2 |
| Andrew Zakhari | 1 |
| Dr. Caroline Pukall | 1 |
| Dr. Robert F. Casper | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometriosis | 34 |
| Dyspareunia | 7 |
| Dysmenorrhea | 6 |
| Pain | 6 |
| Pelvic Pain | 3 |
| Constipation | 2 |
| Alzheimer Disease | 1 |
| Candidiasis | 1 |
| Chronic Pain | 1 |
| Disease | 1 |
Trials
Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.